CD19+ Relapse/Refractory B-ALL
2 clinical trials · Condition
◉ Watch CD19+ Relapse/Refractory B-ALL
| Record | Firm | Date |
|---|---|---|
| CAR-T-19 Cells for Patients With CD19+ Relapse/Refractory B-ALL (NCT05270772) | Chinese PLA General Hospital | 2021-02-25 |
Track CD19+ Relapse/Refractory B-ALL automatically
Every clearance here is in the API, with alerts when new ones post.